Renzo Luzzatti has done nearly everything in the pharmacy space over the past 30 years short of dispensing pills and seeking prior authorization. He knows all too well how the cost of prescription drugs has become a competitive burden for employers. As president of US-Rx CARE, a “fiduciary” pharmacy benefits manager (PBM), his mission is to fix the system’s inherent flaws, slash costs without depriving people of care and steer them away from therapies they shouldn’t be on in the first place.
Mark Cuban's cost plus, while limited to some generics, is transparemt and fiducary.They tell you the cost of the drug, the labor, the shipping, and the markup(profitaaaaaaaaaa0
We are billionare owned tech slaves.
Past time for “financial clensing.”
Mark Cuban's cost plus, while limited to some generics, is transparemt and fiducary.They tell you the cost of the drug, the labor, the shipping, and the markup(profitaaaaaaaaaa0
Unless OptumRx becomes a fiduciary, their recent announcement represents another way to profit from drugs